P. W. Nan and J. H. Richard, “The Role of Telomerase Expression and Telomere Length Maintenance in Human and Mouse,” Journal of Clinical Immunology, Vol. 20, No. 4, 2000, pp. 257-267. doi:10.1023/A:1017223602293
 W. Guenther, “The Viral Origins of Telomeres and Telomerases and Their Important Role in Eukaryogenesis and Genome Maintenance,” Biosemiotics, Vol. 1, No. 2, 2008, pp. 191-206. doi:10.1007/s12304-008-9018-0
 J. Liu, A. Baykal, K. M. Fung, et al., “Human Telomerase Reverse Transcriptase mRNA Is Highly Expressed in Normal Breast Tissues and Down-Regulated in Ductal Carcinoma in Situ,” International Journal of Oncology, Vol. 24, No. 4, 2004, pp. 879-884.
 J. Beesley, H. A. Pickett, S. E. Johnatty, et al., “Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers,” PLoS One, Vol. 6, No. 9, 2001, Article ID: e24987. doi:10.1371/journal.pone.0024987
 C. Poremba, B. Heine, R. Diallo, et al., “Telomerase as a Prognostic Marker in Breast Cancer: High-Throughput Tissue Microarray Analysis of hTERT and hTR,” Journal of Pathology, Vol. 198, No. 2, 2002, pp. 181-189. doi:10.1002/path.1191
 P. de Souza Nascimento, G. Alves and W. Fiedler, “Telomerase Inhibition by an siRNA Directed against hTERT Leads to Telomere Attrition in HT29 Cells,” Oncology Reports, Vol. 16, No. 2, 2006, pp. 423-428.
 J. Li, N. Zhang, L. B. Song, et al., “Astrocyte Elevated Gene-1 Is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival,” Clinical Cancer Research, Vol. 14, No. 11, 2008, pp. 3319-3326. doi:10.1158/1078-0432.CCR-07-4054
 R. Pallini, A. Sorrentino, F. Pierconti, et al., “Telomerase Inhibition by Stable RNA Interference Impairs Tumor Growth and Angiogenesis in Glioblastoma Xenografts,” International Journal of Cancer, Vol. 118, No. 9, 2006, pp. 2158-2167. doi:10.1002/ijc.21613
 N. W. Kim and F. Wu, “Advances in Quantification and Characterization of Telomerase Activity by the Telomeric Repeat Amplification Protocol,” Nucleic Acids Research, Vol. 25, No. 13, 1997, pp. 2595-2597. doi:10.1093/nar/25.13.2595
 H. Wege, M. S. Chui, H. T. Le, et al., “SYBR Green Real-Time Telomeric Repeat Amplification Protocol for the Rapid Quantification of Telomerase Activity,” Nucleic Acids Research, Vol. 31, No. 2, 2003, Article ID: e3-3. doi:10.1093/nar/gng003
 S. M. Hammond, E. Bernstein, D. Beach, et al., “An RNADirected Nuclease Mediates Post-Transcriptional Gene Silencing in Drosophila Cells,” Nature, Vol. 404, No. 6775, 2000, pp. 293-296. doi:10.1038/35005107
 L. Zou, P. Zhang, C. Luo, et al., “ShRNA-Targeted hTERT Suppress Cell Proliferation of Bladder Cancer by Inhibiting Telomerase Activity,” Cancer Chemotherapy and Pharmacology, Vol. 57, No. 3, 2006, pp. 328-334. doi:10.1007/s00280-005-0056-x
 K. Kurvinen, S. Syrjanen and B. Johansson, “Long-Term Suppression of Telomerase Expression in HeLa Cell Clones, Transfected with an Expression Vector Carrying siRNA Targeting hTERT mRNA,” International Journal of Oncology, Vol. 29, No. 1, 2006, pp. 279-288.
 A. P. Cunningham, L. G. Andrews and T. O. Tollefsbol, “Retrovirus-Mediated RNA Interference Targeting hTERT through Stable Expression of Short-Hairpin RNA,” Methods in Molecular Biology, Vol. 405, 2007, pp. 39-46. doi:10.1007/978-1-60327-070-0_5
 M. Nakamura, K. Masutomi, S. Kyo, et al., “Efficient Inhibition of Human Telomerase Reverse Transcriptase Expression by RNA Interference Sensitizes Cancer Cells to Ionizing Radiation and Chemotherapy,” Human Gene Therapy, Vol. 16, No. 7, 2005, pp. 859-68. doi:10.1089/hum.2005.16.859